First-in-human, pharmacokinetic and pharmacodynamic phase I study about Resminostat, Caspian secretion of oral histone deacetylase inhibitor, in patients with advanced solid tumors.
First-in-human, pharmacokinetic and pharmacodynamic phase I study of Resminostat, an oral histone deacetylase inhibitor, in patients with advanced solid tumors.